Shares of ImmunityBio Inc. surged 16.4% on Wednesday, marking their best session in over a month, and extended gains in after ...

Currently, the only approved vaccine for TB is the century-old Bacillus Calmette-Guerin (BCG) vaccine, which is widely used ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...

“Microcomputer management of a vaccine trial.” Computers in Biology and Medicine 18(3 ... “Community Trials of BCG Vaccination.” American Review of Tuberculosis 77:877-907. 50. Phillips, J.F., R.

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

In bladder cancer clinical trials in Europe, the recombinant BCG vaccine has demonstrated potent immunogenicity with CD8+ and CD4+ T cell stimulation and improved safety compared to earlier BCG ...